Breast Cancer RiskWeT-HNPNCT07014553
Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer
A study testing web based nursing navigator programme in people with Breast Cancer Risk, run by Istanbul University - Cerrahpasa at 2 sites in Turkey (Türkiye).
Trial summary
The aim of this project is to determine the effect of the Web-Based Nurse Navigation Program on breast cancer screening behaviors (mammography, BSE, CBE) in women at high risk of breast cancer. Read more about this study
- Who is it for?
- Ages 30 to 70 years, women only
- Conditions the study is for
- Breast Cancer Risk
- What is being tested?
- web based nursing navigator programme
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 104 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 1 Feb 2026to 30 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 70 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Being 30-70 years old,
- Not having been diagnosed with breast cancer,
- Not having been included in a breast health program before,
- Not having had a mammogram in the last year,
- Being at high risk of breast cancer according to the Tyrer-Cuzick Model,
- Having a phone, computer or laptop with internet access,
- Not having a health problem that prevents vision or hearing,
- Being willing to participate in the study.
Who cannot join
- Not being able to read or write,
- Having a history of breast cancer,
- Not being at high risk of breast cancer,
- Being pregnant or postpartum,
- Not agreeing to participate in the study.
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Cancer early diagnosis screening and education center
Istanbul, Büyükçekmece, 34500
Family health center
Istanbul, Büyükçekmece, 34500
About this study
The aim of this project is to determine the effect of the Web-Based Nurse Navigation Program on breast cancer screening behaviors (mammography, BSE, CBE) in women at high risk of breast cancer. The program to be developed within the scope of the project is named as "Web-Based Nurse Navigation Program (WeT-HNP)", which reflects the web-based and navigation concepts.
Read the detailed description
Breast cancer is a very important health problem affecting women's health in the world and in our country. It was reported that 685,000 people died of breast cancer in the world in 2020. The American Cancer Society estimates that approximately 310,720 new cases of invasive breast cancer will be detected in women in the United States in 2024, approximately 56,500 new cases of ductal carcinoma in situ (DCIS) will be detected, and approximately 42,250 women will die from breast cancer. In Turkey, breast cancer is the most common type of cancer in women and the cause of most deaths. In national reports for our country, it was reported that the frequency of breast cancer in women in 2018 was 48.6 per hundred thousand and the number of newly diagnosed patients in the same year was 22,500. Early diagnosis of breast cancer, which is a very important health problem in terms of women's health, reduces mortality and provides the opportunity for breast-conserving surgery. Today, the most effective approach in reducing mortality rates in breast cancer is early diagnosis/screening methods. Early diagnosis/screening methods aim to detect abnormal changes in women's breast tissue at an early stage. Breast self-examination (BSE), clinical breast examination (CBE) and mammography are widely recommended early diagnosis/screening methods for the early detection of breast cancer. In order to detect breast cancer at the earliest stage, it is recommended that women without symptoms in our country have a BSE every month starting at the age of 20, have a CBE once a year, and have a mammogram every 2 years between the ages of 40-69.It is recommended that women at high risk of breast cancer start breast cancer screening earlier and be monitored more frequently than women without symptoms. The American Cancer Society recommends that women at high risk of breast cancer have a mammogram every year after the age of 30.
- Conditions
- Breast Cancer Risk
- Being tested
- web based nursing navigator programme
- Keywords
- breast cancer, nursing, public health nursing, web based, nursing navigator programme
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
web based nursing navigator programmeBehavioural
health education guidance surveillance case management
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental | 6-week web-based nursing navigation programme Receives: Behavioral: web based nursing navigator programme |
| Control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
mammography rates
browsing behavior monitoring form
Measured: baseline, 6 months
rate of breast self-examination
screening behaviors follow-up form
Measured: baseline, 3 months
rate of clinical breast examination
screening behaviors follow-up form
Measured: baseline, 6 months
Secondary outcomes (3)
Health perceptions
Breast Cancer Health Belief Model Scale Results
Measured: baseline, 6 months
Breast cancer fear score
Breast Cancer Fear Scale
Measured: baseline, 6 months
perception of mammography competence
Mammography Competence Scale
Measured: baseline, 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2025
- Study start1 Feb 2026
- Primary completion1 May 2026
- Study completion30 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast Cancer RiskStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 104 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tuğçe çiçekli taşdemir, Istanbul University - Cerrahpasa
- Investigators
- Selda Seçginli, Prof. Dr., Study director, Atlas University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07014553
- Sponsor's protocol ID
- IUC-NURSE-TÇT-01
- Acronym
- WeT-HNP
- Status last verified
- Jul 2025
- First submitted
- 3 Jun 2025
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer
- ClinicalTrials.gov ID
- NCT07014553
- Acronym / sponsor ID
- WeT-HNP / IUC-NURSE-TÇT-01
- Conditions
- Breast Cancer Risk
- Keywords
- breast cancer, nursing, public health nursing, web based, nursing navigator programme
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 104 participants (estimated)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 1 Feb 2026 (actual)
- Primary completion
- 1 May 2026 (actual)
- Study completion
- 30 Sep 2026 (estimated)
- First posted
- 11 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this project is to determine the effect of the Web-Based Nurse Navigation Program on breast cancer screening behaviors (mammography, BSE, CBE) in women at high risk of breast cancer. The program to be developed within the scope of the project is named as "Web-Based Nurse Navigation Program (WeT-HNP)", which reflects the web-based and navigation concepts.
Detailed description
Breast cancer is a very important health problem affecting women's health in the world and in our country. It was reported that 685,000 people died of breast cancer in the world in 2020. The American Cancer Society estimates that approximately 310,720 new cases of invasive breast cancer will be detected in women in the United States in 2024, approximately 56,500 new cases of ductal carcinoma in situ (DCIS) will be detected, and approximately 42,250 women will die from breast cancer. In Turkey, breast cancer is the most common type of cancer in women and the cause of most deaths. In national reports for our country, it was reported that the frequency of breast cancer in women in 2018 was 48.6 per hundred thousand and the number of newly diagnosed patients in the same year was 22,500. Early diagnosis of breast cancer, which is a very important health problem in terms of women's health, reduces mortality and provides the opportunity for breast-conserving surgery. Today, the most effective approach in reducing mortality rates in breast cancer is early diagnosis/screening methods. Early diagnosis/screening methods aim to detect abnormal changes in women's breast tissue at an early stage. Breast self-examination (BSE), clinical breast examination (CBE) and mammography are widely recommended early diagnosis/screening methods for the early detection of breast cancer. In order to detect breast cancer at the earliest stage, it is recommended that women without symptoms in our country have a BSE every month starting at the age of 20, have a CBE once a year, and have a mammogram every 2 years between the ages of 40-69.It is recommended that women at high risk of breast cancer start breast cancer screening earlier and be monitored more frequently than women without symptoms. The American Cancer Society recommends that women at high risk of breast cancer have a mammogram every year after the age of 30.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Experimental | Behavioral: web based nursing navigator programme6-week web-based nursing navigation programme |
| Control group | No intervention | – |
Who may qualify
- Ages
- 30 to 70 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Being 30-70 years old,
- Not having been diagnosed with breast cancer,
- Not having been included in a breast health program before,
- Not having had a mammogram in the last year,
- Being at high risk of breast cancer according to the Tyrer-Cuzick Model,
Key exclusion criteria (5 listed)
- Not being able to read or write,
- Having a history of breast cancer,
- Not being at high risk of breast cancer,
- Being pregnant or postpartum,
- Not agreeing to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| web based nursing navigator programmehealth education guidance surveillance case management | Behavioural | Experimental group |
Primary outcome
mammography rates
Time frame: baseline, 6 months
browsing behavior monitoring form
rate of breast self-examination
Time frame: baseline, 3 months
screening behaviors follow-up form
rate of clinical breast examination
Time frame: baseline, 6 months
screening behaviors follow-up form
3 secondary outcomes
Health perceptions
Time frame: baseline, 6 months
Breast cancer fear score
Time frame: baseline, 6 months
perception of mammography competence
Time frame: baseline, 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer Risk
RecruitingObservational study
Individuals on Hormone Therapy Breast Cancer Screening Pilot
Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
RecruitingObservational study
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
Breast Carcinoma
Not yet recruiting
Culinary And Lifestyle Medicine Education for Cancer Risk Reduction in Survivors of Breast Cancer
Breast Cancer
Recruiting
A Study of Skipping Radiation Therapy in People With Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Selda Seçginli, Prof. Dr. study director
Atlas University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing web based nursing navigator programme in people with Breast Cancer Risk, run by Istanbul University - Cerrahpasa at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mammography rates (time frame: baseline, 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.